Filter posts

BIO Investor Forum Session on Advancing Immuno–Oncology

At the 2016 BIO Investor Forum, the first session held was titled “The Intersection of …

BIO Investor Forum is Next Week: Oct. 18-19

Now in its 15th year, the BIO Investor Forum is set for Oct. 18 – …

Astellas Expands Advocacy Engagement with Focused Outreach

Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives …

BIO’s One-on-One Partnering™ and the Winning Pitch - 2016 BIO Investor Forum

BIO’s One-on-One Partnering™ system will facilitate over 2,000 partnering meetings at this year’s BIO Investor …

Post-election Scenarios to Microbiome Therapies—Diverse Panels at 2016 BIO Investor Forum

Government policy and regulation, investment trends, latest discoveries, drug development, licensing and other topics will …

2016 BIO Animal Biotech Summit Day Two Highlights

Day #2 Session topics specifically focused on Poverty Reduction & Food Security and Biotech & Biodiversity. BIO concluded …

Riding Coast to Coast for Cancer Patients

For 21 days in September, 80 members of Bristol-Myers Squibb’s (BMS) oncology team will cross …

BIO Joins Biotech Week Activities

Global Biotech Week is a week-long string of activities and events across the globe that …

2016 BIO Animal Biotech Summit Day One Highlights

BIO concluded its 2016 Animal Biotech Summit on Friday, September 23, 2016. BIO chose “One Health” …

All Pharma Wants to Be “Patient-Centric” – What Does That Really Mean?

The concept “patient-centricity” has become a pharmaceutical industry buzzword in recent years, making it difficult …